Highlighting innovation

Over two decades ago, the World Health Organization (WHO) sounded the alarm on obesity, declaring it a global epidemic. Fast forward to 2013, and the WHO set an ambitious goal: halt the rise in obesity by 2030. But with just six years left, the numbers tell a different story...

George William Ssendagala

July 11, 2024

To find out investor’s thoughts on the biomaterials sector, we spoke to three members of our BioCapital Network; Sarah Jones - Principal at Zero Carbon Capital, Elisabetta Sakiotis - Analyst at Rockstart, and Josh Armistead-Wood - Senior Associate at Sustainable Ventures.

June 27, 2024

BoobyBiome, a start-up innovating the realm of infant health, is spearheading efforts to redefine neonatal care through a deep understanding of the gut microbiome. Founded by Lydia, Sioned, and Tara, they are dedicated to leveraging cutting-edge science to optimise infant health outcomes, particularly focusing on premature infants.

Joanna Myślińska

June 19, 2024

Whilst biomaterials are entering an exciting era within regenerative medicine, it has become clear the translation of principles across industries has opened the door for biomaterials to heal the planet. In this article we showcase creative interpretations of a biomaterial and their range of potential applications in a strive towards more sustainable products. 

June 12, 2024

Companies looking to get innovative biology to patients around the world need to be aware that it takes a 360-degree view of the intellectual property requirements, and in the case of CRISPR this landscape is becoming more and more convoluted, with companies scrambling to renegotiate licensing laws for GMOs to use in research and industry. Taken together, this points towards an opportunity for Forge Genetics to position themselves perfectly, to create a novel, gold-standard gene-editing technology, supporting innovation throughout the global biotechnology industry.

Aonghus Topham

May 29, 2024

In the ever-evolving landscape of scientificresearch, access to cutting-edge technologies and expertise is pivotal forbreakthrough discoveries. Among the array of analytical techniques, NuclearMagnetic Resonance (NMR) stands out for its ability to provide detailedinsights into the structure, dynamics, and interactions of molecules. However,the challenge lies in accessing NMR instruments and specialized analyticalservices, particularly for researchers and institutions with limited resourcesor in-house expertise.Bruker BioSpin, a pioneering leader inanalytical magnetic resonance instrumentation, has introduced an innovativesolution: Connexus. Connexus serves as adigital bridge, connecting NMR scientists with laboratories equipped withstate-of-the-art instruments and expertise.

Tobias Wingbermühle

May 15, 2024

PentaBind, a biotech start-up from London, aims to drug the undruggable, targeting diseases that have long been considered beyond the reach of conventional drug discovery methods. Recognising that only 15% of the human proteome has been effectively targeted by existing drugs [2], they are pioneering a novel therapeutic approach that combines the high specificity of aptamers with the power of artificial intelligence (AI).

Giovanni Maresca di Serrapriola

March 14, 2024

In the quest to revolutionise cancer diagnosis, BioMavericks emerged amidst the COVID-19 crisis, recognizing a crucial gap in advanced sequencing methods for cancer detection. Their ground-breaking in vitro diagnostic tool, fuelled by proprietary biomarkers, with a sensitivity and specificity of over 97% promises exceptional accuracy in detecting prevalent cancers.

George William Ssendagala

March 6, 2024

Microneedle Solutions (MNS) is on a quest to increase vaccines uptake by manufacturing affordable self-adhesive vaccine patches that patients can use themselves. The self-administration means that, ultimately, MNS’s product can reduce the strain on healthcare systems and increase vaccine uptake, thus reducing health inequality whilst improving access to vaccines globally.

Ana Ivanus

January 31, 2024

Pear Bio is revolutionising the way cancer treatments are assigned to patients. They have developed a functional precision medicine platform by integrating tissue engineering, confocal microscopy, and computer vision into a single patient stratification tool. This facilitates the assessment of the treatment efficacy in the human tumour microenvironment by modelling the impact a drug or a combination of drugs has on the progression of disease.

December 4, 2023